CoChat

The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults

Weaver, Jolanta U., Theventhiran, Lakshmi, Noonan, Kate, Burrin, Jacqueline M., Taylor, Norman F., Norman, Michael R., Monson, John P. · 1994 · Clinical Endocrinology
Cited by 120

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Summary: OBJECTIVE Growth hormone (GH) replacement therapy in hypopituitary adults is associated with sodium and water retention. The underlying mechanisms are incompletely understood and a possible contribution of altered cortisol metabolism or action has not been evaluated. We have investigated the effect of GH replacement therapy on cortisol metabolism, cortisol binding globulin and In‐vitro glucocorticold sensitivity in a group of adult hypopituitary patients. DESIGN AND PATIENTS We studied 19 adult hypopituitary patients (18 adult onset, Y:F, 6:13), who were receiving conventional hydrocortisone (16 patients), thyroxine (14 patients), triiodothyronine (1 patient), sex steroid (9 patients), human chorionic gonadotrophin (1 patient) or desmopressin (6 patients) replacement during a 6‐month, double blind controlled trial of GH therapy (active: placebo, 8:11) followed by a 6‐month open phase of GH (mean dose: 0·2 IU/kg/week, range 0·051‐0·27) and after a 6‐week washout phase following discontinuation of GH therapy. MEASUREMENTS Twenty‐four‐hour urine free cortisol, cortisol metabolites (CoM), ratio 11‐hydroxy/ll‐oxo CoM (F/E) and ratio 5α/β tetrahydrocortisol were measured at 6 months, 12 months and after the 6 week washout phase. Serum cortisol binding globulin was measured basally, at 6 months, 12 months and after washout. Glucocorticold sensitivity was determined in lymphocyte preparations from 8 patients, during GH therapy and after washout, using an In‐vitro technique dependent on dexamethasone suppression of phytohaemagglutinin‐stimulated thymidine Incorporation into DNA. Plasma renin activity and aidosterone were measured after 6‐12 months GH therapy and after washout. RESULTS After 6 months of GH, In patients on hydrocortisone (n= 9), there were significant decreases in CoM (mean decrement 21%, P < 0·01), F/E (mean decreased from 1·27to 1·0, P= 0·04; reference range0·33‐1·29) and 5α/5β tetrahydrocortisol (mean decreased from 0·67 to 0·48, P= 0·01) and a subsequent increase after washout. Patients not on hydrocortisone (n= 2) demonstrated a normal basal F/E falling by 25% on GH therapy but no change in CoM. During 12 months of OH therapy, patients on hydrocortisone (n= 7) demonstrated a further trend to decrement in CoM (P= 0·09) which reversed after washout (P= 0·04). Urine free cortisol tended to fall during OH therapy and Increased significantly following washout after 12 months treatment (P < 0·02). Serum cortisol binding globulin decreased by 20% (P < 0·05) during 12 months GH treatment but remained within the reference range. In‐vitro studies demonstrated a trend to reduced giucocorticoid sensitivity on GH therapy; the maximum inhibition of phytohaemaggiutinin by dexamethasone tended to be less on OH therapy (P= 0·052) and was also lower than in 29 normal volunteers (P < 0·05). There were no significant changes in plasma renin but there was a small increment in aidosterone in recumbent patients (P= 0·04) during the open phase of GH therapy in the placebo arm. CONCLUSIONS GH therapy in hypopltuitary adults is associated with an apparent reduction in availability of administered hydrocortisone as measured by urine cortisol metabolites and urine free cortisol. This effect is unlikely to be clinically significant except possibly in ACTH deficient subjects on suboptimal hydrocortisone replacement. The changes in F/E suggest that GH may directly or indirectly modulate the activity of 11β‐hydroxysteroid dehydrogenase. The apparent decrease in giucocorticoid sensitivity during GH therapy, demonstrated in vitro, merits further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1994.tb01830.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 120

Metadata

Authors
Weaver, J. U., Theventhiran, L., Noonan, K., Burrin, J. M., Taylor, N. F., Norman, M. R., & Monson, J. P.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1994-11
Volume
41
Issue
5
Pages
639-648
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2022101319
Cited by
120
References
4
FWCI
1.95
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. https://app.cochat.ai/papers/10.1111/j.1365-2265.1994.tb01830.x
The paper
Weaver, J. U., Theventhiran, L., Noonan, K., Burrin, J. M., Taylor, N. F., Norman, M. R., & Monson, J. P. (1994). The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1994.tb01830.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.